Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 218 entries
Sorted by: Best Match Show Resources per page
Interdiffusion of the group-III sublattice in In-Ga-As-P/In-Ga-As-P and In-Ga-As/In-Ga-As heterostructures.

Physical review. B, Condensed matter

Gillin WP, Homewood KP, Rao SS.
PMID: 9974813
Phys Rev B Condens Matter. 1994 Sep 15;50(11):8071-8073. doi: 10.1103/physrevb.50.8071.

No abstract available.

Cite
Gillin WP, Homewood KP, Rao SS. Interdiffusion of the group-III sublattice in In-Ga-As-P/In-Ga-As-P and In-Ga-As/In-Ga-As heterostructures. Phys Rev B Condens Matter. 1994;50(11):8071-8073doi: 10.1103/physrevb.50.8071.
Gillin, W. P., Homewood, K. P., & Rao, S. S. (1994). Interdiffusion of the group-III sublattice in In-Ga-As-P/In-Ga-As-P and In-Ga-As/In-Ga-As heterostructures. Physical review. B, Condensed matter, 50(11), 8071-8073. https://doi.org/10.1103/physrevb.50.8071
Gillin, et al. "Interdiffusion of the group-III sublattice in In-Ga-As-P/In-Ga-As-P and In-Ga-As/In-Ga-As heterostructures." Physical review. B, Condensed matter vol. 50,11 (1994): 8071-8073. doi: https://doi.org/10.1103/physrevb.50.8071
Gillin WP, Homewood KP, Rao SS. Interdiffusion of the group-III sublattice in In-Ga-As-P/In-Ga-As-P and In-Ga-As/In-Ga-As heterostructures. Phys Rev B Condens Matter. 1994 Sep 15;50(11):8071-8073. doi: 10.1103/physrevb.50.8071. PMID: 9974813.
Copy Download .nbib Format: NLM
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population.

Journal of arrhythmia

Nielsen JC, Lin YJ, de Oliveira Figueiredo MJ, Sepehri Shamloo A, Alfie A, Boveda S, Dagres N, Di Toro D, Eckhardt LL, Ellenbogen K, Hardy C, Ikeda T, Jaswal A, Kaufman E, Krahn A, Kusano K, Kutyifa V, S Lim H, Lip GYH, Nava-Townsend S, Pak HN, Rodríguez Diez G, Sauer W, Saxena A, Svendsen JH, Vanegas D, Vaseghi M, Wilde A, Bunch TJ, Buxton AE, Calvimontes G, Chao TF, Eckardt L, Estner H, Gillis AM, Isa R, Kautzner J, Maury P, Moss JD, Nam GB, Olshansky B, Molano LFP, Pimentel M, Prabhu M, Tzou WS, Sommer P, Swampillai J, Vidal A, Deneke T, Hindricks G, Leclercq C.
PMID: 32782627
J Arrhythm. 2020 Jun 15;36(4):553-607. doi: 10.1002/joa3.12338. eCollection 2020 Aug.

No abstract available.

Cite
Nielsen JC, Lin YJ, de Oliveira Figueiredo MJ, et al. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population. J Arrhythm. 2020;36(4):553-607doi: 10.1002/joa3.12338.
Nielsen, J. C., Lin, Y. J., de Oliveira Figueiredo, M. J., Sepehri Shamloo, A., Alfie, A., Boveda, S., Dagres, N., Di Toro, D., Eckhardt, L. L., Ellenbogen, K., Hardy, C., Ikeda, T., Jaswal, A., Kaufman, E., Krahn, A., Kusano, K., Kutyifa, V., S Lim, H., Lip, G. Y. H., Nava-Townsend, S., Pak, H. N., Rodríguez Diez, G., Sauer, W., Saxena, A., Svendsen, J. H., Vanegas, D., Vaseghi, M., Wilde, A., Bunch, T. J., Buxton, A. E., Calvimontes, G., Chao, T. F., Eckardt, L., Estner, H., Gillis, A. M., Isa, R., Kautzner, J., Maury, P., Moss, J. D., Nam, G. B., Olshansky, B., Molano, L. F. P., Pimentel, M., Prabhu, M., Tzou, W. S., Sommer, P., Swampillai, J., Vidal, A., Deneke, T., Hindricks, G., & Leclercq, C. (2020). European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population. Journal of arrhythmia, 36(4), 553-607. https://doi.org/10.1002/joa3.12338
Nielsen, Jens Cosedis, et al. "European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population." Journal of arrhythmia vol. 36,4 (2020): 553-607. doi: https://doi.org/10.1002/joa3.12338
Nielsen JC, Lin YJ, de Oliveira Figueiredo MJ, Sepehri Shamloo A, Alfie A, Boveda S, Dagres N, Di Toro D, Eckhardt LL, Ellenbogen K, Hardy C, Ikeda T, Jaswal A, Kaufman E, Krahn A, Kusano K, Kutyifa V, S Lim H, Lip GYH, Nava-Townsend S, Pak HN, Rodríguez Diez G, Sauer W, Saxena A, Svendsen JH, Vanegas D, Vaseghi M, Wilde A, Bunch TJ, Buxton AE, Calvimontes G, Chao TF, Eckardt L, Estner H, Gillis AM, Isa R, Kautzner J, Maury P, Moss JD, Nam GB, Olshansky B, Molano LFP, Pimentel M, Prabhu M, Tzou WS, Sommer P, Swampillai J, Vidal A, Deneke T, Hindricks G, Leclercq C. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population. J Arrhythm. 2020 Jun 15;36(4):553-607. doi: 10.1002/joa3.12338. eCollection 2020 Aug. PMID: 32782627; PMCID: PMC7411224.
Copy Download .nbib Format: NLM
Gender Differences in Insurance, Surgical Admissions and Outcomes at a Kenyan Referral Hospital.

The Journal of surgical research

Gillio AM, Li HW, Bhatia MB, Chepkemoi E, Rutto EJ, Carpenter KL, Saruni SI, Keung CH, Hunter-Squires JL.
PMID: 34340011
J Surg Res. 2021 Dec;268:199-208. doi: 10.1016/j.jss.2021.06.014. Epub 2021 Jul 30.

INTRODUCTION: Gender is an important factor in determining access to healthcare resources. Women face additional barriers, especially in low- and middle-income countries. Surgical costs can be devastating, which can exacerbate engendered disparities. Kenya's National Hospital Insurance Fund (NHIF) aims...

Cite
Gillio AM, Li HW, Bhatia MB, et al. Gender Differences in Insurance, Surgical Admissions and Outcomes at a Kenyan Referral Hospital. J Surg Res. 2021;268:199-208doi: 10.1016/j.jss.2021.06.014.
Gillio, A. M., Li, H. W., Bhatia, M. B., Chepkemoi, E., Rutto, E. J., Carpenter, K. L., Saruni, S. I., Keung, C. H., & Hunter-Squires, J. L. (2021). Gender Differences in Insurance, Surgical Admissions and Outcomes at a Kenyan Referral Hospital. The Journal of surgical research, 268199-208. https://doi.org/10.1016/j.jss.2021.06.014
Gillio, Anna M, et al. "Gender Differences in Insurance, Surgical Admissions and Outcomes at a Kenyan Referral Hospital." The Journal of surgical research vol. 268 (2021): 199-208. doi: https://doi.org/10.1016/j.jss.2021.06.014
Gillio AM, Li HW, Bhatia MB, Chepkemoi E, Rutto EJ, Carpenter KL, Saruni SI, Keung CH, Hunter-Squires JL. Gender Differences in Insurance, Surgical Admissions and Outcomes at a Kenyan Referral Hospital. J Surg Res. 2021 Dec;268:199-208. doi: 10.1016/j.jss.2021.06.014. Epub 2021 Jul 30. PMID: 34340011.
Copy Download .nbib Format: NLM
Evaluation of HPV-Related Biomarkers in Anal Cytological Samples from HIV-Uninfected and HIV-Infected MSM.

Pathogens (Basel, Switzerland)

Rollo F, Latini A, Giuliani M, Giglio A, Donà MG, Benevolo M.
PMID: 34358038
Pathogens. 2021 Jul 13;10(7). doi: 10.3390/pathogens10070888.

Men who have sex with men (MSM) harbor the highest risk for anal carcinoma, mainly caused by Human Papillomavirus (HPV). The use of HPV-related biomarkers in the screening for this neoplasia is still debated. We assessed the association between...

Cite
Rollo F, Latini A, Giuliani M, et al. Evaluation of HPV-Related Biomarkers in Anal Cytological Samples from HIV-Uninfected and HIV-Infected MSM. Pathogens. 2021;10(7)doi: 10.3390/pathogens10070888.
Rollo, F., Latini, A., Giuliani, M., Giglio, A., Donà, M. G., & Benevolo, M. (2021). Evaluation of HPV-Related Biomarkers in Anal Cytological Samples from HIV-Uninfected and HIV-Infected MSM. Pathogens (Basel, Switzerland), 10(7), . https://doi.org/10.3390/pathogens10070888
Rollo, Francesca, et al. "Evaluation of HPV-Related Biomarkers in Anal Cytological Samples from HIV-Uninfected and HIV-Infected MSM." Pathogens (Basel, Switzerland) vol. 10,7 (2021). doi: https://doi.org/10.3390/pathogens10070888
Rollo F, Latini A, Giuliani M, Giglio A, Donà MG, Benevolo M. Evaluation of HPV-Related Biomarkers in Anal Cytological Samples from HIV-Uninfected and HIV-Infected MSM. Pathogens. 2021 Jul 13;10(7). doi: 10.3390/pathogens10070888. PMID: 34358038; PMCID: PMC8308578.
Copy Download .nbib Format: NLM
Incidence and clearance of anal high-risk Human Papillomavirus infection and their risk factors in men who have sex with men living with HIV.

Scientific reports

Donà MG, Giuliani M, Rollo F, Vescio MF, Benevolo M, Giglio A, Giuliani E, Morrone A, Latini A.
PMID: 34996988
Sci Rep. 2022 Jan 07;12(1):184. doi: 10.1038/s41598-021-03913-5.

HIV-infected men who have sex with men (MSM) display the highest prevalence of anal infection by high-risk Human Papillomaviruses (hrHPVs) and incidence of anal carcinoma. Anal specimens were genotyped by the Linear Array. Incidence and clearance of anal infection...

Cite
Donà MG, Giuliani M, Rollo F, et al. Incidence and clearance of anal high-risk Human Papillomavirus infection and their risk factors in men who have sex with men living with HIV. Sci Rep. 2022;12(1):184doi: 10.1038/s41598-021-03913-5.
Donà, M. G., Giuliani, M., Rollo, F., Vescio, M. F., Benevolo, M., Giglio, A., Giuliani, E., Morrone, A., & Latini, A. (2022). Incidence and clearance of anal high-risk Human Papillomavirus infection and their risk factors in men who have sex with men living with HIV. Scientific reports, 12(1), 184. https://doi.org/10.1038/s41598-021-03913-5
Donà, Maria Gabriella, et al. "Incidence and clearance of anal high-risk Human Papillomavirus infection and their risk factors in men who have sex with men living with HIV." Scientific reports vol. 12,1 (2022): 184. doi: https://doi.org/10.1038/s41598-021-03913-5
Donà MG, Giuliani M, Rollo F, Vescio MF, Benevolo M, Giglio A, Giuliani E, Morrone A, Latini A. Incidence and clearance of anal high-risk Human Papillomavirus infection and their risk factors in men who have sex with men living with HIV. Sci Rep. 2022 Jan 07;12(1):184. doi: 10.1038/s41598-021-03913-5. PMID: 34996988.
Copy Download .nbib Format: NLM
Impact of cerebrospinal fluid flow study in patients undergoing intrathecal chemotherapy via ventricular catheter reservoir.

Journal of neuro-oncology

Eltobgy M, Huntoon K, Musgrave N, Shaikhouni A, Hardesty DA, Giglio P, Elder JB.
PMID: 33860429
J Neurooncol. 2021 May;153(1):161-167. doi: 10.1007/s11060-021-03756-0. Epub 2021 Apr 15.

PURPOSE: Leptomeningeal carcinomatosis (LMC) is a form of CNS cancer metastasis with severe morbidity. Intrathecal chemotherapy (ITC) administration through an implanted ventricular catheter reservoir (IVCR) is often utilized. Additionally, a nuclear imaging flow study can be performed prior to...

Cite
Eltobgy M, Huntoon K, Musgrave N, et al. Impact of cerebrospinal fluid flow study in patients undergoing intrathecal chemotherapy via ventricular catheter reservoir. J Neurooncol. 2021;153(1):161-167doi: 10.1007/s11060-021-03756-0.
Eltobgy, M., Huntoon, K., Musgrave, N., Shaikhouni, A., Hardesty, D. A., Giglio, P., & Elder, J. B. (2021). Impact of cerebrospinal fluid flow study in patients undergoing intrathecal chemotherapy via ventricular catheter reservoir. Journal of neuro-oncology, 153(1), 161-167. https://doi.org/10.1007/s11060-021-03756-0
Eltobgy, Mostafa, et al. "Impact of cerebrospinal fluid flow study in patients undergoing intrathecal chemotherapy via ventricular catheter reservoir." Journal of neuro-oncology vol. 153,1 (2021): 161-167. doi: https://doi.org/10.1007/s11060-021-03756-0
Eltobgy M, Huntoon K, Musgrave N, Shaikhouni A, Hardesty DA, Giglio P, Elder JB. Impact of cerebrospinal fluid flow study in patients undergoing intrathecal chemotherapy via ventricular catheter reservoir. J Neurooncol. 2021 May;153(1):161-167. doi: 10.1007/s11060-021-03756-0. Epub 2021 Apr 15. PMID: 33860429.
Copy Download .nbib Format: NLM
Rhythm Control of Atrial Fibrillation: The Earlier the Better?.

Circulation

Gillis AM, Wilton SB.
PMID: 33900832
Circulation. 2021 Apr 27;143(17):1639-1641. doi: 10.1161/CIRCULATIONAHA.120.051383. Epub 2021 Apr 26.

No abstract available.

Cite
Gillis AM, Wilton SB. Rhythm Control of Atrial Fibrillation: The Earlier the Better?. Circulation. 2021;143(17):1639-1641doi: 10.1161/CIRCULATIONAHA.120.051383.
Gillis, A. M., & Wilton, S. B. (2021). Rhythm Control of Atrial Fibrillation: The Earlier the Better?. Circulation, 143(17), 1639-1641. https://doi.org/10.1161/CIRCULATIONAHA.120.051383
Gillis, Anne M, and Wilton, Stephen B. "Rhythm Control of Atrial Fibrillation: The Earlier the Better?." Circulation vol. 143,17 (2021): 1639-1641. doi: https://doi.org/10.1161/CIRCULATIONAHA.120.051383
Gillis AM, Wilton SB. Rhythm Control of Atrial Fibrillation: The Earlier the Better?. Circulation. 2021 Apr 27;143(17):1639-1641. doi: 10.1161/CIRCULATIONAHA.120.051383. Epub 2021 Apr 26. PMID: 33900832.
Copy Download .nbib Format: NLM
Racial and Ethnic Differences in the Management of Atrial Fibrillation.

CJC open

Tamirisa KP, Al-Khatib SM, Mohanty S, Han JK, Natale A, Gupta D, Russo AM, Al-Ahmad A, Gillis AM, Thomas KL.
PMID: 34993443
CJC Open. 2021 Sep 13;3(12):S137-S148. doi: 10.1016/j.cjco.2021.09.004. eCollection 2021 Dec.

Atrial fibrillation (AF) is the most common clinical arrhythmia, and it results in adverse outcomes and increased healthcare costs. Racial and ethnic differences in AF management, although recognized, are poorly understood. This review summarizes racial differences in AF epidemiology,...

Cite
Tamirisa KP, Al-Khatib SM, Mohanty S, et al. Racial and Ethnic Differences in the Management of Atrial Fibrillation. CJC Open. 2021;3(12):S137-S148doi: 10.1016/j.cjco.2021.09.004.
Tamirisa, K. P., Al-Khatib, S. M., Mohanty, S., Han, J. K., Natale, A., Gupta, D., Russo, A. M., Al-Ahmad, A., Gillis, A. M., & Thomas, K. L. (2021). Racial and Ethnic Differences in the Management of Atrial Fibrillation. CJC open, 3(12), S137-S148. https://doi.org/10.1016/j.cjco.2021.09.004
Tamirisa, Kamala P, et al. "Racial and Ethnic Differences in the Management of Atrial Fibrillation." CJC open vol. 3,12 (2021): S137-S148. doi: https://doi.org/10.1016/j.cjco.2021.09.004
Tamirisa KP, Al-Khatib SM, Mohanty S, Han JK, Natale A, Gupta D, Russo AM, Al-Ahmad A, Gillis AM, Thomas KL. Racial and Ethnic Differences in the Management of Atrial Fibrillation. CJC Open. 2021 Sep 13;3(12):S137-S148. doi: 10.1016/j.cjco.2021.09.004. eCollection 2021 Dec. PMID: 34993443; PMCID: PMC8712595.
Copy Download .nbib Format: NLM
Bright and Efficient Sensitized Near-Infrared Photoluminescence from an Organic Neodymium-Containing Composite Material System.

Journal of the American Chemical Society

Lyu C, Li H, Zhou S, Liu G, Wyatt PB, Gillin WP, Ye H.
PMID: 34676770
J Am Chem Soc. 2021 Nov 03;143(43):17915-17919. doi: 10.1021/jacs.1c06827. Epub 2021 Oct 22.

Intense organic neodymium (Nd

Cite
Lyu C, Li H, Zhou S, et al. Bright and Efficient Sensitized Near-Infrared Photoluminescence from an Organic Neodymium-Containing Composite Material System. J Am Chem Soc. 2021;143(43):17915-17919doi: 10.1021/jacs.1c06827.
Lyu, C., Li, H., Zhou, S., Liu, G., Wyatt, P. B., Gillin, W. P., & Ye, H. (2021). Bright and Efficient Sensitized Near-Infrared Photoluminescence from an Organic Neodymium-Containing Composite Material System. Journal of the American Chemical Society, 143(43), 17915-17919. https://doi.org/10.1021/jacs.1c06827
Lyu, Chen, et al. "Bright and Efficient Sensitized Near-Infrared Photoluminescence from an Organic Neodymium-Containing Composite Material System." Journal of the American Chemical Society vol. 143,43 (2021): 17915-17919. doi: https://doi.org/10.1021/jacs.1c06827
Lyu C, Li H, Zhou S, Liu G, Wyatt PB, Gillin WP, Ye H. Bright and Efficient Sensitized Near-Infrared Photoluminescence from an Organic Neodymium-Containing Composite Material System. J Am Chem Soc. 2021 Nov 03;143(43):17915-17919. doi: 10.1021/jacs.1c06827. Epub 2021 Oct 22. PMID: 34676770.
Copy Download .nbib Format: NLM
Sentinel Lymph Node Sampling in Robot-Assisted Staging of Endometrial Cancer.

Southern medical journal

Curcio E, Miller B, Giglio A, Akoluk A, Erler B, Bosscher J, Borowsky M, Hicks V, ElSahwi K.
PMID: 34729610
South Med J. 2021 Nov;114(11):680-685. doi: 10.14423/SMJ.0000000000001319.

OBJECTIVE: Sentinel lymph node (SLN) sampling in endometrial cancer staging has become an acceptable standard. Indocyanine green dye injected into the cervix and detected by near-infrared light is technically simple and sensitive. We aimed to evaluate SLN sampling in...

Cite
Curcio E, Miller B, Giglio A, et al. Sentinel Lymph Node Sampling in Robot-Assisted Staging of Endometrial Cancer. South Med J. 2021;114(11):680-685doi: 10.14423/SMJ.0000000000001319.
Curcio, E., Miller, B., Giglio, A., Akoluk, A., Erler, B., Bosscher, J., Borowsky, M., Hicks, V., & ElSahwi, K. (2021). Sentinel Lymph Node Sampling in Robot-Assisted Staging of Endometrial Cancer. Southern medical journal, 114(11), 680-685. https://doi.org/10.14423/SMJ.0000000000001319
Curcio, Erin, et al. "Sentinel Lymph Node Sampling in Robot-Assisted Staging of Endometrial Cancer." Southern medical journal vol. 114,11 (2021): 680-685. doi: https://doi.org/10.14423/SMJ.0000000000001319
Curcio E, Miller B, Giglio A, Akoluk A, Erler B, Bosscher J, Borowsky M, Hicks V, ElSahwi K. Sentinel Lymph Node Sampling in Robot-Assisted Staging of Endometrial Cancer. South Med J. 2021 Nov;114(11):680-685. doi: 10.14423/SMJ.0000000000001319. PMID: 34729610.
Copy Download .nbib Format: NLM
Remote Monitoring of Cardiovascular Implantable Electronic Devices in Canada: Survey of Patients and Device Health Care Professionals.

CJC open

Kelly SE, Campbell D, Duhn LJ, Giddens K, Gillis AM, AbdelWahab A, Nault I, Raj SR, Lockwood E, Basta J, Doucette S, Wells GA, Parkash R.
PMID: 34027341
CJC Open. 2020 Nov 20;3(4):391-399. doi: 10.1016/j.cjco.2020.11.010. eCollection 2021 Apr.

BACKGROUND: Remote monitoring is used to supplement in-clinic follow-up for patients with cardiac implantable electronic devices (CIEDs) every 6-12 months. There is a need to optimize remote management for CIEDs because of the consistent increases in CIED implants over...

Cite
Kelly SE, Campbell D, Duhn LJ, et al. Remote Monitoring of Cardiovascular Implantable Electronic Devices in Canada: Survey of Patients and Device Health Care Professionals. CJC Open. 2020;3(4):391-399doi: 10.1016/j.cjco.2020.11.010.
Kelly, S. E., Campbell, D., Duhn, L. J., Giddens, K., Gillis, A. M., AbdelWahab, A., Nault, I., Raj, S. R., Lockwood, E., Basta, J., Doucette, S., Wells, G. A., & Parkash, R. (2021). Remote Monitoring of Cardiovascular Implantable Electronic Devices in Canada: Survey of Patients and Device Health Care Professionals. CJC open, 3(4), 391-399. https://doi.org/10.1016/j.cjco.2020.11.010
Kelly, Shannon E, et al. "Remote Monitoring of Cardiovascular Implantable Electronic Devices in Canada: Survey of Patients and Device Health Care Professionals." CJC open vol. 3,4 (2021): 391-399. doi: https://doi.org/10.1016/j.cjco.2020.11.010
Kelly SE, Campbell D, Duhn LJ, Giddens K, Gillis AM, AbdelWahab A, Nault I, Raj SR, Lockwood E, Basta J, Doucette S, Wells GA, Parkash R. Remote Monitoring of Cardiovascular Implantable Electronic Devices in Canada: Survey of Patients and Device Health Care Professionals. CJC Open. 2020 Nov 20;3(4):391-399. doi: 10.1016/j.cjco.2020.11.010. eCollection 2021 Apr. PMID: 34027341; PMCID: PMC8129436.
Copy Download .nbib Format: NLM
Targeted Therapy for BRAF Mutant Brain Tumors.

Current treatment options in oncology

Rayi A, Alnahhas I, Ong S, Giglio P, Puduvalli VK.
PMID: 34613491
Curr Treat Options Oncol. 2021 Oct 06;22(11):105. doi: 10.1007/s11864-021-00901-9.

OPINION STATEMENT: Molecular heterogeneity has confounded attempts to target individual pathways in brain tumors. However, gliomas with BRAF mutations have been identified as being uniquely vulnerable to targeted therapies. Such mutations are predominantly seen in brain tumors of the...

Cite
Rayi A, Alnahhas I, Ong S, et al. Targeted Therapy for BRAF Mutant Brain Tumors. Curr Treat Options Oncol. 2021;22(11):105doi: 10.1007/s11864-021-00901-9.
Rayi, A., Alnahhas, I., Ong, S., Giglio, P., & Puduvalli, V. K. (2021). Targeted Therapy for BRAF Mutant Brain Tumors. Current treatment options in oncology, 22(11), 105. https://doi.org/10.1007/s11864-021-00901-9
Rayi, Appaji, et al. "Targeted Therapy for BRAF Mutant Brain Tumors." Current treatment options in oncology vol. 22,11 (2021): 105. doi: https://doi.org/10.1007/s11864-021-00901-9
Rayi A, Alnahhas I, Ong S, Giglio P, Puduvalli VK. Targeted Therapy for BRAF Mutant Brain Tumors. Curr Treat Options Oncol. 2021 Oct 06;22(11):105. doi: 10.1007/s11864-021-00901-9. PMID: 34613491.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 218 entries